Top Clinical Trials companies in France by EBITDA Margin
France
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
20.65%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
| 2 |
-14.60%
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
| 3 |
-50.59%
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
| 4 |
-77.84%
|
Dec. 31, 2023 | USD 3.95 | 0.89% |
|
France |
|
| 5 |
-88.12%
|
Dec. 31, 2023 | USD 3.27 | -7.78% |
|
France |
|
| 6 |
-100.09%
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
| 7 |
-135.45%
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
| 8 |
-155.83%
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
| 9 |
-157.55%
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
| 10 |
-198.16%
|
Dec. 31, 2023 | USD 2.07 | 0.33% |
|
France |
|
| 11 |
-556.11%
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
| 12 |
-583.86%
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
| 13 |
-785.86%
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
| 14 |
-886.00%
|
Dec. 31, 2023 | USD 7.79 | 1.73% |
|
France |
|
| 15 |
-900.14%
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
| 16 |
-956.80%
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
| 17 |
-1,090.11%
|
Dec. 31, 2023 | USD 1.42 | -1.61% |
|
France |
|
| 18 |
-1,202.39%
|
Dec. 31, 2023 | USD 3.93 | 1.44% |
|
France |
|
| 19 |
-2,882.64%
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
|
| 20 |
-5,031.72%
|
Dec. 31, 2023 | USD 1.97 | -2.73% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest EBITDA Margin ?
The Clinical Trials company in France with the highest EBITDA Margin is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at 20.65%.
-
Which Clinical Trials company in France has the lowest EBITDA Margin ?
The Clinical Trials company in France with the lowest EBITDA Margin is Crossject SA (Paris Stock Exchange: ALCJ.PA) at -5,031.72%.
-
What are the top 10 Clinical Trials companies in France by EBITDA Margin ?
The top 10 Clinical Trials companies in France by EBITDA Margin are Eurofins-Cerep SA, Innate Pharma S.A., Aelis Farma SA, Genfit S.A., Median Technologies SA, Nanobiotix S.A., Valbiotis SA, MedinCell S.A., Novacyt S.A. and Advicenne S.A..
-
What are the bottom 10 Clinical Trials companies in France by EBITDA Margin ?
The bottom 10 Clinical Trials companies in France by EBITDA Margin are Crossject SA, ABIVAX SA, Predilife S.A., Affluent Medical SA, AB Science S.A., Adocia SA, MaaT Pharma SA, OSE Immunotherapeutics SA, Inventiva S.A. and DBV Technologies S.A..
